Company news
EirGenix, Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Transcenta Therapeutics Announces Strategic Collaboration and Non-exclusive Licensing Agreement to Advance Integrated Continuous Biomanufacturing and Expand Global Access to Affordable Biologics
December 27, 2025
Correction: EirGenix, Inc.
November 12, 2025
EirGenix Signed The Commercial Licensinse Agreement for It's Second HER2 Biosimilar Asset EG1206A
November 12, 2025
The Company’s Board of Directors Resolved to Issue Employee Stock Warrants.
August 11, 2022
Announcement of Board approve the permission of managers for competitive actions.
August 11, 2022
The Board of Directors Appointed the 3rd term Remuneration Committee Member.
August 11, 2022
Announcement of the Construction Design and Consulting Fee for New Plant.
August 11, 2022
Announcement of the Production Line Expansion and Production Equipment at Zhubei Facility. (Budget Increase)
August 11, 2022
Announcement of the tenure expired of Remuneration Committee of 2nd Board of Directors.
June 10, 2022
Announcement of the appointment of the 3rd term Audit Committee members.
June 10, 2022
Announcement of AGM's approval of suspension of the non-competition restriction on the 5th directors or representatives of directors.
June 10, 2022
Shareholders Elect Board of Directors; Board of Directors Unanimously Elect Dr. Lee-Cheng Liu as Chairman.
June 10, 2022
EirGenix: Important resolutions of EirGenix's 2022 Annual Shareholders' Meeting.
June 10, 2022
Announcement of Election of Directors at 2022 Annual Shareholders’Meeting.
June 10, 2022
Announcement of the Board of Directors resolved to update the vesting conditions of employee restricted stock awards in 2022.
April 19, 2022
Announcement of Completion of the Capital Reduction Registration due to the RSA Write-off
April 18, 2022
Announcement for Replacement of Representative of Juristic Person as Director.
March 29, 2022
Announcement of the Board of Directors resolution of the issuance of the private placement of securities.
March 22, 2022
Announcement of the Board of Directors resolution of the convening of the 2022 Annual Shareholders' Meeting.
March 22, 2022
Announcement of the Board of Directors Resolution on the first issuance of new shares for employee restricted stock awards in 2022.
March 22, 2022
The Board of Directors resolved not to distribute dividends.
March 22, 2022
Announcement of the Board of Directors approval of the cancellation of restricted shares to employee stock awards.
March 22, 2022
EirGenix To announce the acquisition of major assets.
March 9, 2022